Clinical Trial Update: An Open-label, Single-Arm Study to Evaluate the Safety and Rabies Virus Antibody Titers of Intramuscularly Administered Rabies Immune Globulin (Human) [Phase 1]

View source ↗

Summary

This clinical trial update reports on a Phase 1 open-label, single-arm study evaluating the safety and rabies antibody titers after intramuscular administration…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Rabies Immune Globulin (Human) (rabies immune globulin (human))

Snippet

Sponsor: Grifols Therapeutics LLC | Conditions: Rabies | Phase 1 | Status: COMPLETED